Home › › Turna Ray

Articles Authored by Turna Ray

Jul 11, 2017

Controversial Gum Disease Risk Test Highlights Precision Medicine Marketing, Regulatory Issues

Geneticists and periodontists point to financial conflicts, the lack of genetics knowhow, and regulatory gaps for the availability of a test they say should have never come to market.

Jun 29, 2017

Genomic Health Kidney Cancer Test Gauges Recurrence Risk in Study, Not Benefit to Pfizer's Sutent

Premium

The test, developed with Pfizer, could identify renal cancer patients who would experience recurrence, but not who would benefit from adjuvant Sutent.

Jun 23, 2017

After Approval of Next-Gen Sequencing CDx Panel, Thermo Fisher Seeks Rapid Expansion of Indications

Premium

The initial FDA approval of Thermo Fisher's NGS panel test for personalizing cancer treatment may allow rapid expansion to new indications.

Jun 05, 2017

PARP Inhibitor Shows Benefit in BRCA-Mutated Breast Cancer Subpopulation at ASCO

Premium

The first randomized study to show a PARP inhibitor benefits advanced breast cancer patients is also a sign of the expanding utility of BRCA testing in precision medicine.

Jun 03, 2017

Loxo Oncology to Seek FDA Approval for Pan-Cancer Drug in Patients with TRK Fusions

Premium

Data presented at ASCO showing 76 percent of cancer patients responded to larotrectinib could lead to the availability of the first tissue-agnostic targeted drug.

Jun 01, 2017

Lab Group Backs Draft Bill Proposing Dx Regulatory Reform; Finds Points of Agreement With FDA Paper

Premium

Entering a new chapter with a new leader, ACLA lends support to a draft bill that would regulate lab tests not as medical devices but as in vitro clinical tests.

May 30, 2017

Intermountain's Edited Cancer Panel Reducing Rate of Tests Rejected Due to Insufficient Samples

Premium

The leaner panel, an option for patients who lack sufficient tissue samples for more comprehensive profiling, has helped reduce test rejection rates by 80 percent.

May 26, 2017

Expanded Keytruda Approval Signals New Phase for Precision Medicine, May Benefit NGS Panel Makers

Premium

The belief among genomics experts that one day drugs would be given based on genomic abnormalities that cut across tumor types became reality this week.

May 23, 2017

NorthShore, Invitae Partnering to Advance NGS Cancer Risk Test for Proactive Screening

Premium

The partners will combine the analysis of high-risk inherited genes and several hundred SNPs into a single NGS test for inherited cancer risk.

May 22, 2017

Cancer Patients Missing Personalized Therapy Due to Quality Issues for Genetic Tests

Analyzing utilization data, Diaceutics found that issues around 13 genetic tests prevent around 78,000 patients from getting personalized, targeted treatments each year.

more

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.